Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
04/2005
04/26/2005US6884803 Phenylalkynes
04/26/2005US6884265 A stable direct dyes, hair dyes, like oxidation color dyes, chemical resistance, photostability, weatherproofing, wash and wear; comprising imidazolinium, triazolium and pyridinium groups
04/26/2005CA2280137C Sizing of paper
04/26/2005CA2239053C Diphenyl pyridyl ethane derivatives as pde iv inhibitors
04/26/2005CA2213124C Benzoyl derivatives
04/21/2005WO2005035514A2 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups
04/21/2005WO2005035508A2 Method for producing acyl urea derivatives, salts of said acyl urea derivatives, and the use thereof as pesticides
04/21/2005WO2005035501A1 Novel olefin derivative
04/21/2005WO2005035500A2 Therapeutic agents useful for treating pain
04/21/2005WO2005035494A1 Pyridylamino compounds and methods of use thereof
04/21/2005WO2005035473A2 Method for preparing ladderanes from pre-oriented polyenes
04/21/2005WO2005035471A1 Ether derivative
04/21/2005WO2005034960A1 Treatment of diseases associated with the egr-1 enhancer element
04/21/2005WO2005034870A2 Amide compounds and ion channel ligands and uses thereof
04/21/2005WO2005034867A2 Thioether-substituted benzamides as inhibitors of factor xa
04/21/2005WO2005034856A2 Targeted drug-formaldehyde conjugates and methods of making and using the same
04/21/2005WO2005004606A3 Pyridinylanilides
04/21/2005WO2004089286A3 Novel compounds and compositions as protein kinase inhibitors
04/21/2005WO2004062601A3 Antibacterial agents
04/21/2005US20050085667 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
04/21/2005US20050085644 Antidiabetic agents; insulin resistance
04/21/2005US20050085643 Process for producing high-purity 2,3-pyridinedicarboxylic acid
04/21/2005US20050085642 Drugs; agricultural chemicals; electrography photosensitive materials
04/21/2005US20050085541 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
04/21/2005US20050085538 Administering strylacrylonitrile compound; antiproliferative agents; anticancer agents
04/21/2005US20050085527 Catalysts for the polymerization of unsaturated compounds
04/21/2005US20050085523 Imidazolyl and pyrazolyl ethyne compounds
04/21/2005US20050085517 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
04/21/2005US20050085516 2-W-diaminocarboxylic acid compounds
04/21/2005US20050085515 Active compounds with carbamic acid for diseases such as cancer, leukemia, atheriosclerosis, alzheimers disease or arthritis
04/21/2005US20050085512 Amides that inhibit vanilloid receptor subtype 1 (VR1) receptor
04/21/2005US20050085497 Anticholesterol agents; reducing blood serum lipids; anticancer agents; antiarthritic agents; antiinflammatory agents; antitumor agents; immunosuppressants; obesity; hypotensive agents
04/21/2005US20050085474 difluoroamine compounds
04/21/2005US20050084763 low melting electrolyte comprising salts where the anionic charge is delocalized, mixed with metallic salts, polar polymers and/or aprotic solvents
04/21/2005US20050084463 Antiinflammatory, antiarthritic agents, analgesics for pain caused by diabetic assoicated conditions, pneumoconiosis, angina, menstruation or cancer
04/21/2005US20050081313 And an oxidation base; couplers such as N-(3,5-diaminopyrid-2-yl)pyrrolidine; strong, uniform dyeing results between the end and the root, resistant to external agents, capable of giving varied shades
04/21/2005CA2541809A1 Thioether-substituted benzamides as inhibitors of factor xa
04/21/2005CA2541590A1 Treatment of diseases associated with the egr-1 enhancer element
04/21/2005CA2540978A1 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups
04/21/2005CA2539587A1 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics
04/20/2005EP1524267A1 Substituted benzylaminoalkylene heterocycles
04/20/2005EP1523476A2 2,4-disubstituted-pyridine n-oxides useful as hiv reverse transcriptase inhibitors
04/20/2005EP1523471A1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments
04/20/2005EP1349847B1 Oxybenzamides derivatives as factor xa inhibitors
04/20/2005EP1029851B1 Piperazine compounds and medicinal use thereof
04/20/2005EP1015431B1 2-aminopyridines as inhibitors of cyclooxygenase-2
04/20/2005EP0766669B1 Tri-substituted phenyl derivatives useful as pde iv inhibitors
04/20/2005CN1608071A Method of converting functional group through halogen-metal exchange reaction
04/20/2005CN1608059A Bipyridyl derivatives as a highly selective cyclooxygenase-2 inhibitor
04/20/2005CN1608055A Compounds for the treatment of metabolic disorders
04/20/2005CN1607935A Primary intermediates for oxidative coloration of hair
04/20/2005CN1197860C FAB I inhibitors
04/19/2005US6881846 Antiproliferative agents
04/19/2005US6881755 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
04/19/2005US6881743 Pyridine matrix metalloproteinase inhibitors
04/19/2005US6881738 Analogs of choline for neuroprotection and cognitive enhancement in neurodegenerative disorders
04/19/2005US6881736 Inhibit the vitronectin receptor and are useful for the treatment of inflammation, cancer and cardiovascular disorders, such as atherosclerosis and restenosis, and diseases wherein bone resorption is a factor, such as
04/19/2005US6881735 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
04/19/2005US6881727 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
04/19/2005US6881698 Ion liquids derived from Lewis acid based on titanium, niobium, tantalum, tin or antimony, and uses thereof
04/19/2005US6881536 Particle based electrochemiluminescent assays
04/19/2005CA2260989C Method of production and method of separation of 2,4'-dipyridyl derivatives and methods of production of benzoxazepine derivatives and salts thereof
04/19/2005CA2116631C Process for the preparation of aqueous nicotinaldehyde
04/14/2005WO2005033119A1 Supramolecular compounds and their use as antitumour and antiviral agents
04/14/2005WO2005033105A2 Vanilloid receptor ligands and their use in treatments
04/14/2005WO2005033081A1 4-piridinylmethylsulphonamide derivatives as fungicidal plant protection agents
04/14/2005WO2005033079A1 Novel antifungal agent comprising heterocyclic compound
04/14/2005WO2005032493A2 Amide compounds as ion channel ligands and uses thereof
04/14/2005WO2005032471A2 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
04/14/2005WO2005012241A3 p-38 KINASE INHIBITORS
04/14/2005WO2005011654A3 Pyridyl derivatives and their use as therapeutic agents
04/14/2005WO2005011653A3 Pyridazine derivatives and their use as therapeutic agents
04/14/2005WO2005009928A3 Preparation and use of alkylating agents
04/14/2005US20050080281 Bridged bi-aromatic ligands, catalysts, processes for polymerizing and polymers therefrom
04/14/2005US20050080271 Peptidomimetic ligands for cellular receptors and ion channels
04/14/2005US20050080265 Sleep disorders; side effect reduction
04/14/2005US20050080141 Amino diols useful in the treatment of alzheimer's disease
04/14/2005US20050080119 Diaminopropionic acid derivatives
04/14/2005US20050080111 Antagonists of liver X receptors; control of cholesterol, triglyceride, or bile acid levels; 6-(1-Benzyl-1H-pyrazol-4-yl)-1-(2,4-difluoro-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile
04/14/2005US20050080106 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes
04/14/2005US20050080102 Compound and uses thereof
04/14/2005US20050080100 Pyridylamino compounds and methods of use thereof
04/14/2005US20050080090 Such as 7-(Imidazolo[4,5-b]pyridin-1-yl)-1-(1-methylpyrrolidin-3-yl)naphthalene; for treating depression, anxiety, eating disorders, drug abuse, cluster headache, migraine, pain, and other disorders arising from deficient serotonergic neurotransmission
04/14/2005US20050080073 Sulfonylaminocarboxiylic acid N-arylamides as guanylate cyclase activators
04/14/2005US20050080058 New vitamin D derivatives with carbo-or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments
04/14/2005CA2541299A1 Amide compounds as ion channel ligands and uses thereof
04/14/2005CA2540828A1 Heterocyclic amides and sulfonamides
04/14/2005CA2540640A1 Vanilloid receptor ligands and their use in treatments
04/14/2005CA2540452A1 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
04/14/2005CA2537486A1 4-piridinylmethylsulphonamide derivatives as fungicidal plant protection agents
04/13/2005EP1522313A1 Combination therapy of radiation and valdecoxib for the treatment of neoplasia
04/13/2005EP1521820A1 Use of metal complex compounds as oxidation catalysts
04/13/2005EP1521753A2 A process to prepare pioglitazone via several intermediates.
04/13/2005EP1521748A1 Novel anthracene derivatives and the use thereof as a medicament
04/13/2005EP1521733A1 Modulators of the glucocorticoid receptor
04/13/2005EP1521528A1 Malononitrile compounds and their use as pesticides
04/13/2005EP1268498B1 Cardioprotective phosphonates
04/13/2005EP1073640B1 Naphthalene derivatives, their production and use
04/13/2005CN1606431A Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes
04/13/2005CN1196697C Thiophene-ethyl thiourea compounds and their use in treatment of HIV